Sensitization in transplantation: Assessment of Risk 2022 Working Group Meeting Report

Anat R. Tambur*, Oriol Bestard, Patricia Campbell, Anita S. Chong, Marta Crespo, Mandy L. Ford, Howard M. Gebel, Sebastiaan Heidt, Michelle Hickey, Annette Jackson, Vasilis Kosmoliaptsis, Carmen Lefaucheur, Kevin Louis, Roslyn B. Mannon, Michael Mengel, Anna Morris, David F. Pinelli, Elaine F. Reed, Carrie Schinstock, Jean Luc TaupinNicole Valenzuela, Chris Wiebe, Peter Nickerson

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

14 Citations (Scopus)
4 Downloads (Pure)


The Sensitization in Transplantation: Assessment of Risk workgroup is a collaborative effort of the American Society of Transplantation and the American Society of Histocompatibility and Immunogenetics that aims at providing recommendations for clinical testing, highlights gaps in current knowledge, and proposes areas for further research to enhance histocompatibility testing in support of solid organ transplantation. This report provides updates on topics discussed by the previous Sensitization in Transplantation: Assessment of Risk working groups and introduces 2 areas of exploration: non–human leukocyte antigen antibodies and utilization of human leukocyte antigen antibody testing measurement to evaluate the efficacy of antibody-removal therapies.

Original languageEnglish
Pages (from-to)133-149
Number of pages17
JournalAmerican Journal of Transplantation
Issue number1
Publication statusPublished - Jan 2023
Externally publishedYes

Bibliographical note

Publisher Copyright: © 2022 The Author(s)


Dive into the research topics of 'Sensitization in transplantation: Assessment of Risk 2022 Working Group Meeting Report'. Together they form a unique fingerprint.

Cite this